Glycyrol suppresses collagen-induced arthritis by regulating autoimmune and inflammatory responses

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Fu, Yanxia ^a   Zhou, Hailing ^a   Wang, Shuangyan ^a   Wei, Qun ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ACETYLSALICYLIC ACID; ANTIRHEUMATIC AGENT; CARBON; GLYCYROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CYTOKINE; FLAVONOID; IMMUNOSUPPRESSIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE EROSION; CAPILLARY PERMEABILITY; CARBON METABOLISM; COLLAGEN-INDUCED ARTHRITIS; DELAYED HYPERSENSITIVITY; DRUG DOSE COMPARISON; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; TOXICITY TESTING; TRANSCRIPTION TERMINATION; TREATMENT OUTCOME; ANIMAL; ANTAGONISTS AND INHIBITORS; ARTHRITIS, EXPERIMENTAL; ARTICULAR CARTILAGE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; DBA MOUSE; DOWN REGULATION; DRUG EFFECTS; DRUG SCREENING; GENETIC TRANSCRIPTION; GENETICS; HYPERSENSITIVITY, DELAYED; IMMUNOLOGY; INFLAMMATION; MACROPHAGE; METABOLISM; PATHOLOGY; PHAGOCYTOSIS; PHYSIOLOGY; PHYTOTHERAPY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; CAPILLARY PERMEABILITY; CARTILAGE, ARTICULAR; CYTOKINES; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; FLAVONOIDS; HYPERSENSITIVITY, DELAYED; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INTERLEUKIN-2; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; PHAGOCYTOSIS; PHYTOTHERAPY; TRANSCRIPTION, GENETIC;

EID: 84904479802     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098137     Document Type: Article

References (34)

1. Vinay DS, Kwon BS (2012) Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritis. Cytokine. 57:305-12
2. Pierer M, Wagner U, Rossol M, Ibrahim S (2011) Toll-like receptor 4 is involved in inflammatory and joint destructive pathways in collagen-induced arthritis in DBA1J mice. PLoS One 6:e23539
3. Gabriel SE, Michaud K (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res. Ther. 11:229
4. Umar S, Asif M, Sajad M (2012) Anti-inflammatory and antioxidant activity of Trachyspermumammi seeds in collagen induced arthritis in rats. J Drug Dev Res 4:210-9
5. Wang JH, Shih KS, Liou JP, Wu YW, Chang AS, et al. (2012) Anti-arthritic effects of magnolol in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in a rat arthritis model. PLoS One 7:e31368
6. McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7:429-42 (Pubitemid 46834849)
7. Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet. 376:1094-108
8. Yocum DE, Furst DE, Kaine JL, Baldassare AR, Stevenson JT, et al. (2003) Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial. Arthritis Rheum. 48:3328-37 (Pubitemid 37531899)
9. Kitahara K, Kawai S (2007) Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis. Curr. Opin. Rheumatol. 19:238-45 (Pubitemid 46597460)
10. Hong JC, Kahan BD (2000) Immunosuppressive agents in organ transplantation: past, present, and future. Semin. Nephrol. 20:108-25 (Pubitemid 30158481)
11. Bennett WM, Norman DJ (1986) Action and toxicity of cyclosporine. Annu. Rev. Med. 37:215-24: 215-24
12. Thomson AW, Whiting PH, Simpson JG (1984) Cyclosporine: immunology, toxicity and pharmacology in experimental animals. Agents Actions. 15:306-27 (Pubitemid 15188250)
13. Venkatesha SH, Rajaiah R, Berman BM, Moudgil KD (2011) Immunomodulation of Autoimmune Arthritis by Herbal CAM. Evid. Based. Complement Alternat. Med. 2011:986797. doi: 10.1155/2011/986797. Epub;%2010 Dec 22.:986797
14. Li J, Tu Y, Tong L, Zhang W, Zheng J, et al. (2010) Immunosuppressive activity on the murine immune responses of glycyrol from Glycyrrhiza uralensis via inhibition of calcineurin activity. Pharm. Biol. 48:1177-84
15. Jin Y, Kim S, Kim Y, Kim S, Kim H (2008) The first total synthesis of glycyrol. Tetrahedron Letters 49:6835-7
16. Brand DD, Latham KA, Rosloniec EF (2007) Collagen-induced arthritis. Nat. Protoc. 2:1269-75 (Pubitemid 46901304)
17. Nishikawa M, Myoui A, Tomita T, Takahi K, Nampei A, et al. (2003) Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. Arthritis Rheum. 48:2670-81 (Pubitemid 37129445)
18. Strid J, Tan LA, Strobel S, Londei M, Callard R (2007) Epicutaneous immunization with type II collagen inhibits both onset and progression of chronic collagen-induced arthritis. PLoS One 2:e387
19. Feng YH, Zhou WL, Wu QL, Li XY, Zhao WM, et al. (2002) Low dose of resveratrol enhanced immune response of mice. Acta Pharmacol. Sin. 23:893-7
20. Hua Y, Gao Q, Wen L, Zhao M (2012) Structural characterisation of acidsoluble polysaccharides in the fruiting body of Dictyophora indusiata and their immunomodulatory activities. Food Chem 132:739-43
21. Stallard N, Whitehead A (1995) Reducing animal numbers in the fixed-dose procedure. Hum. Exp. Toxicol. 14:315-23
22. Huang LJ, Gao WY, Li X, Zhao WS, Huang LQ, et al. (2010) Evaluation of the in vivo anti-inflammatory effects of extracts from Pyrus bretschneideri Rehd. J. Agric. Food Chem. 58:8983-7
23. Cen J, Shi M, Yang Y, Fu Y, Zhou H, et al. (2013) Isogarcinol is a new immunosuppressant. PLoS One 8:e66503
24. Kockx M, Jessup W, Kritharides L (2010) Cyclosporin A and atherosclerosis-cellular pathways in atherogenesis. Pharmacol. Ther. 128:106-18
25. Yoo SA, Park BH, Park GS, Koh HS, Lee MS, et al. (2006) Calcineurin is expressed and plays a critical role in inflammatory arthritis. J. Immunol. 177:2681-90
26. Rusnak F, Mertz P (2000) Calcineurin: form and function. Physiol Rev. 80:1483-521
27. Baksh S, Burakoff SJ (2000) The role of calcineurin in lymphocyte activation. Semin. Immunol. 12:405-15
28. Mauri C, Williams RO, Walmsley M, Feldmann M (1996) Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur. J Immunol. 26:1511-8 (Pubitemid 26229996)
29. Brennan FM, McInnes IB (2008) Evidence that cytokines play a role in rheumatoid arthritis. J. Clin. Invest. 118:3537-45
30. Kim HS, Kim AR, Park HJ, Park DK, Kim dK, et al. (2011) Morus bombycis Koidzumi extract suppresses collagen-induced arthritis by inhibiting the activation of nuclear factor-kappaB and activator protein-1 in mice. J. Ethnopharmacol. 136:392-8
31. Gorman CL, Cope AP (2008) Immune-mediated pathways in chronic inflammatory arthritis. Best. Pract. Res. Clin. Rheumatol. 22:221-38 (Pubitemid 351606942)
32. Lubberts E, van den BL, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo CJ, et al. (2003) IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol. 170:2655-62
33. Pickens SR, Volin MV, Mandelin AM, Kolls JK, Pope RM, et al. (2010) IL-17 contributes to angiogenesis in rheumatoid arthritis. J. Immunol. 184:3233-41 34.
34. van den Berg WB, Miossec P (2009) IL-17 as a future therapeutic target for rheumatoid arthritis. Nat. Rev. Rheumatol. 5:549-53